Belite Bio (BLTE) Tax Rate (2023 - 2024)

Belite Bio (BLTE) posted quarterly Tax Rate of 0.07% for Q3 2024, up 8.0% year-over-year from 0.06% in Q4 2023, and up 190.53% on a QoQ basis from 0.08% in Q1 2024.

Belite Bio (BLTE) Tax Rate (2023 - 2024) Analysis & Trends

Belite Bio (BLTE) has reported Tax Rate for 2 consecutive years, with 0.07% the latest figure, recorded in Q3 2024.

  • In Q3 2024, Tax Rate rose 8.0% year-over-year to 0.07%; the TTM figure through Dec 2024 stood at 0.0% (up 7.0% YoY), while the FY2024 annual figure was 0.02%, up 49.0% from the prior year.
  • Tax Rate came in at 0.07% for Q3 2024 at Belite Bio, up from 0.08% in the prior quarter.
  • The five-year high for Tax Rate was 0.07% in Q3 2024, with the low at 0.09% in Q1 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Tax Rate (Qtr)
1 Genmab A 276,399.99 Bn 276,398.47 Bn 831.00 Mn -
2 Akari Therapeutics 1,217.26 Bn 1,217.26 Bn - 5.61%
3 BeOne Medicines 419.38 Bn 414.59 Bn 1.35 Bn 12.29%
4 Vertex Pharmaceuticals 126.54 Bn 119.30 Bn 2.59 Bn 17.68%
5 Pharming 110.17 Bn 110.12 Bn 65.80 Mn 9.35%
6 Regeneron Pharmaceuticals 64.97 Bn 56.22 Bn 3.31 Bn 12.51%
7 Argenx Se 56.44 Bn 56.44 Bn 1.18 Bn 13.70%
8 Alnylam Pharmaceuticals 40.09 Bn 37.08 Bn 959.66 Mn 7.07%
9 Revolution Medicines 37.15 Bn 37.15 Bn - -
10 Belite Bio 96.77 Mn 96.77 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2024 0.07
Sep 30, 2024 0.07
Mar 31, 2024 -0.08
Mar 31, 2024 -0.08
Dec 31, 2023 0.01
Dec 31, 2023 0.01
Sep 30, 2023 -0.01
Sep 30, 2023 -0.01
Jun 30, 2023 -0.04
Jun 30, 2023 -0.04
Mar 31, 2023 -0.09
Mar 31, 2023 -0.09